Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Breast Cancer Research and Treatment|June 1, 2013
HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patientsSoo Youn Bae, Yoon La Choi, Sangmin Kim, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 1, 2019
EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast CancerYisun Jeong, Soo Youn Bae, Daeun You, et al.
BMC Cancer|April 25, 2008
CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cellsJong Bin Kim, Eunyoung Ko, Wonshik Han, et al.
Oncology Reports|October 4, 2011
Effect of berberine on p53 expression by TPA in breast cancer cellsSangmin Kim, Jeonghun Han, Nam-Young Kim, et al.
The Journal of Surgical Research|March 3, 2012
Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cellsSangmin Kim, Jeonghun Han, Se Kyung Lee, et al.
Journal of Ethnopharmacology|September 1, 2009
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cellsSangmin Kim, Sung Hoon Kim, Sung Mo Hur, et al.
Pharmacology|November 13, 2010
Pifithrin-α, an inhibitor of p53 transactivation, up-regulates COX-2 expression through an MAPK-dependent pathwaySangmin Kim, Jeonghun Han, Se Kyung Lee, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 3, 2009
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cellsSangmin Kim, Jae Hyuck Choi, Hye In Lim, et al.
Pageof 18